The influence of the PDE inhibitors on cough reflex in guinea pigs

Bratislava Medical Journal

Volumn 112, Issue 3, 2011, Pages 131-135

  Mokry, J ^a   Nosalova, G ^a  

^a University Hospital in Martin   (Slovakia)

Author keywords

Antitussive drugs; Cough reflex; PDE inhibitors; Phosphodiesterase; Xanthine derivatives

Indexed keywords

ANTITUSSIVE AGENT; CITRIC ACID; OVALBUMIN; PHOSPHODIESTERASE INHIBITOR; THEOBROMINE; THEOPHYLLINE;

ANIMAL; ARTICLE; BRONCHUS HYPERREACTIVITY; CHEMICALLY INDUCED DISORDER; COUGHING; DRUG EFFECT; GUINEA PIG; IMMUNOLOGY; MALE; PATHOPHYSIOLOGY; REFLEX;

ANIMALS; ANTITUSSIVE AGENTS; BRONCHIAL HYPERREACTIVITY; CITRIC ACID; COUGH; GUINEA PIGS; MALE; OVALBUMIN; PHOSPHODIESTERASE INHIBITORS; REFLEX; THEOBROMINE; THEOPHYLLINE;

EID: 79954478083     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Korpas J, Nosalova G. Pharmacotherapy of the cough. Osveta, Martin, 1991, 336 p.
2. Mokra D, Mokry J. Inflammation in meconium aspiration syndro me: targets for pharmacological modulation. Curr Pediatr Rev 2007; 3:248-263
3. Nosalova G, Strapkova A. Pharmacological profile of xanthine deri vatives. Stud Pneumol Phthiseol 2000; 5: 228-230.
4. Nosalova G. New opinions on the mechanism of action of xanthine derivatives. Slovakofarma Revue 2000; 10: 51-55.
5. Antoniu SA. Roflumilast for the treatment of chronic obstructive pulmonary disease. Curr Opin Investig Drugs 2006; 7:412-417
6. Lipworth BJ. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet 2005; 365: 167-175.
7. Nosalova G, Mokry J. The mechanism of action of xanthine deriva tives and suppression of cough. Acta Med Mart 2001; 1: 14-18.
8. Mokry J, Mokra D, Nosalova G, Beharkova M, Feherova Z. Influ ence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity. J Physiol Pharmacol 2008; 59 (SUPPL 6): 473-482.
9. Usmani OS, Belvisi MG, Patel HJ, Crispino N, Birrell MA, Kor-bonits M, Korbonits D, Barnes PJ. Theobromine inhibits sensory ner ve activation and cough. FASEB J 2005; 19(2): 231-3.
10. Ishiura Y, Fujimura M, Nobata K, Abo M, Oribe T, Myou S, Nakamura H. Phosphodiesterase 3 inhibition and cough in elderly as thmatics. Cough 2005; 1: 11.
11. Fujimura M, Liu Q. Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigs. Pulm Pharmacol Ther 2007; 20; 543-117.
12. Mokry J, Nosalova G. Evaluation of the cough reflex and airway reactivity in toluene- and ovalbumin- induced airway hyperresponsive-ness. J Physiol Pharmacol 2007; 58 (SUPPL 5): 419^126.
13. Franova S, Nosalova G, Pechanova O, Sutovska M. Red wine polyphenolic compounds inhibit tracheal smooth muscle contraction during allergen-induced hyperreactivity of the airways. J Pharm Phar macol 2007; 59: 727-732.
14. Sutovska M, Nosalova G, Franova S. The role of potassium ion channels in cough and other reflexes of the airways. J Physiol Pharmacol 2007; 58: 673-683.
15. Sutovska M, Franova S, Sutovsky J. The influence of animal species on the relationship between ATP-sensitive potassium ion channels and defense reflexes of the airways. Bratisl Med J 2009; 110 (5), 269-275.
16. Beavo JA. Cyclic nucleotide phosphodiesterases: functional impli cations of multiple isoforms. Physiol Rev 1995; 75: 725-748.
17. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: Mo lecular regulation to clinical use. Pharmacol Rev 2006; 58: 488-520.
18. Karish SB, Gagnon JM. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor. Ann Pharmacother 2006; 40: 1096-1104.
19. Matsuda F, Sugahara K, Sugita M, Sadohara T, Kiyota T, Te-rasaki H. Comparative effect of amrinone, aminophylline and diltia-zem on rat airway smooth muscle. Acta Anaesthesiol Scand 2000; 44: 763-766.
20. Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 1995; 8: 637-642.
21. Spina D, Landells LJ, Page CP. The role of theophylline and phos phodiesterase-4 isoenzyme inhibitors as antiinflammatory drugs. Clin Exp Allergy 1998; 28 (SUPPL 3): 24-34.
22. Giembycz MA. Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors. Curr Opin Pharmacol 2005; 5: 238-244.
23. Mokry J, Nosalova G, Mokra D. Influence of xanthine derivatives on cough and airway reactivity in guinea pigs. J Physiol Pharmacol 2009; 60: (SUPPL 5): 87-91.
24. Sebkhi A, Strange JW, Phillips SC, Wharton J, Wilkins MR. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation 2003; 107: 3230-3235.
25. Toward TJ, Smith N, Broadley KJ. Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of irways disease. Am J Respir Crit Care Med 2004; 169: 227-234.
26. Plevkova J, Kollarik M, Brozmanova M, Revallo M, Varechova S, Tatar M. Modulation of experimentally-induced cough by stimula tion of nasal mucosa in cats and guinea pigs. Respiratory Physiol Neurobiol 2004; 142: 225-235.